Levalbuterol Hydrochloride
Product Images NDC 76204-003

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levalbuterol Hydrochloride (NDC 76204-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levalbuterol 01)

Chemical structure of Levalbuterol Hydrochloride showing the molecular arrangement of atoms including hydroxyl groups and a hydrochloride component.*

FDA Label Image

Figure 1 (Levalbuterol 02)

A line graph showing mean change in FEV1 (%) over 8 hours for different treatments including Levalbuterol at 1.25 and 0.63 doses, Racemic mixture 2.5, and placebo (PBO). The x-axis represents time in hours, and the y-axis represents mean change in FEV1 (%) with data points and sample sizes for each group.*

FDA Label Image

Figure 2 (Levalbuterol 03)

A line graph showing mean change in FEV1 (%) over time (hours) for four groups: Lev 1.25, Lev 0.63, Rac 2.5, and placebo (PBO). The graph compares lung function changes across 8 hours post-treatment, with legend markers indicating sample sizes for each group.*

FDA Label Image

Figure 3 (Levalbuterol 04)

A line graph depicting the mean change in FEV1 (%) over time (hours) for different treatments, including Levalbuterol at 0.63 and 0.31 doses, Rac at 2.5 and 1.25 doses, and placebo. The graph shows various response curves for each group over a 4-hour period with sample sizes noted for each.*

FDA Label Image

Figure 4 (Levalbuterol 05)

A line graph depicting the mean change in FEV1 (%) over time (hours) comparing different dosages of Levalbuterol Hydrochloride (Lev 0.63 and Lev 0.31) and Racemic albuterol (Rac 2.5 and Rac 1.25) against placebo (Pbo). The graph shows time on the x-axis (from -0.5 to 4 hours) and mean change in FEV1 (%) on the y-axis, illustrating the drug effect over a 4-hour period.*

FDA Label Image

Figure 1 (Instructions for Use)

An instructional diagram showing a twist-off tab mechanism. The image labels the tab locations and includes a shaded arrow indicating the direction to twist the tab off, illustrating how to open the unit-dose vial for Levalbuterol Hydrochloride by Ritedose Pharmaceuticals, LLC.*

FDA Label Image

Figure 2 (Instructions for Use)

An instructional black and white line drawing showing a person holding a suppository near the opening of a lower body area, demonstrating the method of rectal administration by insertion with one hand stabilizing and the other hand guiding the suppository.*

FDA Label Image

Figure 3 (Instructions for Use)

An instructional illustration showing a hand aligning a medication cartridge with an inhaler device. The image demonstrates how to insert the cartridge into the inhaler by pressing it into place as indicated by an arrow. No text or branding is visible in the illustration.*

FDA Label Image

Figure 4 (Instructions for Use)

An instructional illustration showing a person using a device to inhale medication. The image depicts the person placing the mouthpiece of the inhaler into their mouth to administer a dose.*

FDA Label Image

Principal Display Panel (0.63 mg/3 mL Vial Carton)

Levalbuterol HCl Inhalation Solution 0.63 mg/3 mL sterile unit-dose vials packaging label from Ritedose Pharmaceuticals, LLC. The carton contains 24 sterile unit-dose vials, each vial holding 3 mL of solution. The label states the potency expressed as levalbuterol and specifies the product is for oral inhalation only and Rx only.*

FDA Label Image

Principal Display Panel (1.25 mg/3 mL Vial Carton)

Levalbuterol HCl Inhalation Solution 1.25 mg/3 mL carton label from Ritedose Pharmaceuticals, LLC. The packaging indicates 24 sterile unit-dose vials, each containing 3 mL of solution. The label prominently displays the strength as 1.25 mg per 3 mL dose, for oral inhalation use only, and includes the NDC 76204-003-24.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.